Skip to content
StockMarketAgent
Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

NSE/LAURUSLABS stock hub

NSE/LAURUSLABS has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

NSE/LAURUSLABSis not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
663.1B
National Stock Exchange of India
Market data

Live price

Current market quote for this ticker.

Current price
NSE/LAURUSLABS
In the news

Latest news · NSE/LAURUSLABS

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E60.3
P25 24.9P50 32.4P75 45.7
Trailing P/E74.7
P25 24.8P50 35.9P75 56.9
ROE17.7
P25 6.3P50 13.6P75 18.1
ROIC13.7
P25 4.1P50 10.3P75 17.9
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All NSE/LAURUSLABS market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
236
Groups with data
11
Currency
INR
Showing 236 of 236 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

20
MetricValue
Country
India
Country code
IN
Employees
6,167
Employees Change
160%
Employees Change Percent
2.66
Enterprise value
INR 688.5B
Exchange
National Stock Exchange of India
Financial currency
INR
First seen
2026-05-10
Industry
Drug Manufacturers - Specialty & Generic
Isin
INE947Q01028
Last refreshed
2026-05-10
Market cap
INR 663.1B
Price
INR 1,225
Price currency
INR
Rev Per Employee
11,136,452.08x
Sector
Healthcare
Sic
2833
Symbol
nse/LAURUSLABS
Website
https://www.lauruslabs.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

15
MetricValue
Earnings Yield
1.34%
EV Earnings
77.46x
EV/EBIT
50.89x
EV/EBITDA
37.56x
EV/FCF
124.37x
EV/Sales
10.02x
FCF yield
0.83%
Forward P/E
60.3x
P/B ratio
12.21x
P/E ratio
74.67x
P/S ratio
9.66x
PE Ratio10 Y
53.02x
PE Ratio3 Y
101.86x
PE Ratio5 Y
73.21x
PEG ratio
1.12x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

27
MetricValue
EBIT Margin
19.69%
EBITDA Margin
26.68%
FCF margin
8.06%
Gross margin
60.75%
Gross Profit
INR 41.7B
Gross Profit Growth
40.71%
Gross Profit Growth Q
35.84%
Gross Profit Growth3 Y
9.47%
Gross Profit Growth5 Y
9.8%
Net Income
INR 8.9B
Net Income Growth
148.04%
Net Income Growth Q
19.46%
Net Income Growth Quarters
6%
Net Income Growth Years
2%
Net Income Growth3 Y
4%
Net Income Growth5 Y
-2.01%
Pretax Margin
17.21%
Profit Margin
12.94%
Profit Per Employee
INR 1.4M
Profitable Years
14
ROA
8.52
Roa5y
7.72
ROCE
19.67
ROE
17.74
Roe5y
15.86
ROIC
13.65
Roic5y
12.25

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

23
MetricValue
Cagr1y
101.31%
Cagr3y
57.65%
Cagr5y
20.65%
Div CAGR3
0%
Div CAGR5
0%
EPS Growth
147.7
EPS Growth Q
19.42
EPS Growth Quarters
6
EPS Growth Years
2
EPS Growth3 Y
3.96
EPS Growth5 Y
-2.09
FCF Growth3 Y
428.97%
FCF Growth5 Y
65.76%
OCF Growth
169.84%
OCF Growth10 Y
33.81%
OCF Growth3 Y
17.77%
OCF Growth5 Y
17.24%
Revenue Growth
23.66x
Revenue Growth Q
5.99x
Revenue Growth Quarters
6x
Revenue Growth Years
2x
Revenue Growth3 Y
4.37x
Revenue Growth5 Y
7.37x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

22
MetricValue
Asset Turnover
INR 0.69
Assets
INR 105.1B
Cash
INR 1.1B
Current Assets
INR 48.3B
Current Liabilities
INR 36.4B
Debt
INR 25.2B
Debt EBITDA
INR 1.37
Debt Equity
INR 0.46
Debt FCF
INR 4.55
Equity
INR 54.3B
Interest Coverage
7.92
Liabilities
INR 50.8B
Long Term Assets
INR 56.8B
Long Term Liabilities
INR 14.4B
Net Cash
INR -24B
Net Cash By Market Cap
INR -3.63
Net Debt EBITDA
INR 1.31
Net Debt Equity
INR 0.44
Net Debt FCF
INR 4.34
Tangible Book Value
INR 50.4B
Tangible Book Value Per Share
INR 93.26
WACC
6.11

Liquidity

Current-asset coverage and working-capital efficiency metrics.

6
MetricValue
Current ratio
1.33
Inventory Turnover
1.26
Net Working Capital
INR 28.8B
Quick ratio
0.62
Working Capital
INR 11.9B
Working Capital Turnover
INR 6.91

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

10
MetricValue
Buyback Yield
-0.13%
Dividend Growth
66.67%
Dividend Growth Years
1%
Dividend per share
INR 1.6
Dividend Years
10
Dividend Yield
0.13%
Ex Div Date
2026-05-08
Last Dividend
INR 1.2
Payout Frequency
Semi-Annual
Payout Ratio
9.71%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

37
MetricValue
1Y total return
101.21%
200-day SMA
979.3
3Y total return
291.94%
50-day SMA
1,066.6
50-day SMA vs 200-day SMA
50over200
5Y total return
155.57%
All Time High
1,237.9
All Time High Change
-1.05%
All Time High Date
2026-05-08
All Time Low
59
All Time Low Change
1,976.1%
All Time Low Date
2020-03-13
ATR
34.92
Beta
0.35
Beta1y
0.73
Beta2y
0.49
Ch YTD
10.55
High
1,237.9
High52
1,237.9
High52 Date
2026-05-08
High52ch
-0.59%
Low
1,206
Low52
572.3
Low52 Date
2025-05-09
Low52ch
114.05%
Ma50ch
14.84%
Price vs 200-day SMA
25.08%
RSI
71.92
RSI Monthly
73.43
RSI Weekly
70.31
Sharpe ratio
2.35x
Sortino ratio
3.93
Total Return
-0%
Tr YTD
10.66
Tr1m
15.95%
Tr1w
5.12%
Tr3m
28.99%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

6
MetricValue
Operating Income
INR 13.5B
Operating Income Growth
116.4
Operating Income Growth Q
29.55
Operating Income Growth3 Y
1.47
Operating Income Growth5 Y
0.03
Operating margin
19.69

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

7
MetricValue
Float
363,277,628%
Net Borrowing
-3,127,000,000
Shares Insiders
28.32%
Shares Institutions
34.2%
Shares Out
539,856,582
Shares Qo Q
-0.24%
Shares Yo Y
0.13%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

63
MetricValue
Adjusted FCF
INR 5.4B
Average Volume
2,099,500.9x
Bv Per Share
98.16
CAPEX
INR -10.7B
Ch1m
15.84
Ch1w
5.02
Ch1y
100.6
Ch3m
28.86
Ch3y
288.2
Ch5y
151.3
Ch6m
24.72
Change
1.53%
Change From Open
1.57
Close
1,206.5
Days Gap
-0.04
Depreciation Amortization
4,800,500,000
Dollar Volume
2,397,199,119.3
Earnings Date
2026-04-30
EBIT
INR 13.5B
EBITDA
INR 18.3B
EPS
INR 16.45
F Score
8
FCF
INR 5.5B
FCF EV Yield
0.8x
FCF Per Share
INR 10.25
Financing CF
-5,247,200,000
Fiscal Year End
March
Founded
2,005
Goodwill
2,463,000,000
Graham Number
190.61138
Graham Upside
-84.44
Income Tax
INR 2.9B
Investing CF
-10,886,600,000
Is Primary Listing
1
Last Earnings Date
2026-04-30
Last Report Date
2026-03-31
Last Split Date
2020-09-29
Last Split Type
Forward
Lynch Fair Value
INR 82.25
Lynch Upside
-93.29
Ma150
1,015.9
Ma150ch
20.57%
Ma20
1,129.9
Ma20ch
8.41%
Net CF
131,200,000
Next Earnings Date
2026-07-24
Open
1,206
P FCF Ratio
119.8
P OCF Ratio
40.84
Payment Date
2026-05-30
Position In Range
59.25
Ppne
48,792,200,000
Price Date
2026-05-08
Price EBITDA
INR 36.18
Ptbv Ratio
13.17
Relative Volume
0.94x
Revenue
68,678,500,000x
SBC By Revenue
0.16x
Share Based Comp
109,400,000
Tax By Revenue
4.25x
Tax Rate
24.7%
Tr6m
24.84%
Volume
1,957,057
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

NSE/LAURUSLABS dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield
+0.1%
$1.60 annual per share
Payout ratio
+9.7%
Share of earnings returned as dividends. Below 60% is generally sustainable.
5Y dividend CAGR
0.0%
1 consecutive years of growth
Total shareholder yield
-0.0%
Next ex-dividend date: 2026-05-08
Performance

NSE/LAURUSLABS stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
+101.2%
S&P 500 1Y: n/a
3Y total return
+291.9%
S&P 500 3Y: n/a
5Y total return
+155.6%
S&P 500 5Y: n/a
10Y total return
n/a
S&P 500 10Y: n/a
Ownership

Who owns NSE/LAURUSLABS?

Insider, institutional, and short-interest positioning.

Institutional ownership
+34.2%
Share of float held by funds and institutions
Insider ownership
+28.3%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
+0.1%
Negative means the company is buying back shares.
Technical

NSE/LAURUSLABS momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
71.9
Above 70: short-term overbought
Price vs 200-day MA
+25.1%
50/200-day relationship not available
Beta (5Y)
0.35
Less volatile than the market
Sharpe ratio
2.35
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About NSE/LAURUSLABS

Hub-level FAQ points readers to the deeper analysis pages.

What is the current nse/LAURUSLABS stock rating?

nse/LAURUSLABS is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full nse/LAURUSLABS analysis?

The full report lives at /stocks/nse/LAURUSLABS/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for nse/LAURUSLABS?

The latest report frames nse/LAURUSLABS around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the nse/LAURUSLABS page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.